24. Februar 2023 – Swissmedic published an overview of new authorisations 2022. 47 human medicinal products with new active substances were authorised. The overview shows the indications and the type and duration of the authorisation procedures. Swissmedic is also participating in two benchmarking studies to compare the authorisation times with those of the leading partner authorities. The results of these studies will be published during the course of 2023. The overview shows which procedures the applicants used, how long the authorisation processes lasted, and for which indications the medicines were authorised.

For more information, see here.